TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
DTIL

Precision BioSciences Inc

Healthcare · Biotechnology

6.50$ -2.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement DTIL
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
0.0% 0.0% 0.0% 35.9% 16.9% 6.7% 8.0%
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
129.8% 313.4% 414.6% 370.6% 403.8% 99.7% 183.8% 109.5% 86.7% 158.1%
87.9% 123.6% 125.6% 121.5% 148.5% 34.3% 164.5% 80.2% 51.4% 94.1%
216.7% 437.1% 540.2% 492.1% 552.2% 134.1% 348.3% 189.8% 138.1% 252.2%
-125.8% -338.9% -440.2% -392.1% -452.2% -34.1% -248.3% -89.8% -38.1% -152.2%
0.0% 0.0% 0.0% 0.8% 3.4% 0.1% 4.4% 4.6% 2.6% 4.2%
-117.7% -325.4% -423.0% -417.6% -448.9% -26.5% -290.5% -87.3% 10.4% -136.0%
-0.1% -11.6% 17.2% -43.1% 42.9% 0.3% 44.9% 55.9%
-117.6% -325.4% -423.0% -417.6% -448.9% -26.5% -444.8% -125.8% 10.4% -133.4%
-116.7% -314.9% -401.4% -392.9% -408.5% -17.5% -250.2% -65.8% 19.7% -123.8%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?